eGFR (ml/min/1.73 m2) | Actual bodyweight (kg) | |||
<60 | 60 - 80 | 81 - 100 | >100 | |
>90 | 750 mg q8 | 1000 mg q8 | 1250 mg q8 | 1500 mg q8 |
50 - 90 | 750 mg q12 | 1000 mg q12 | 1250 mg q12 | 1500 mg q12 |
15 - 49 | 750 mg q24 | 1000 mg q24 | 1250 mg q24 | 1500 mg q24 |
<15 or RRT | 750 mg ×1 | 1000 mg ×1 | 1250 mg ×1 | 1500 mg ×1 |
Therapeutic drug monitoring 1. For patients dosed every 8 - 12 hours, check trough 30 minutes prior to 4th dose 2. For patients dosed every 24 hours, check trough 30 minutes prior to 3rd dose Patients with eGFR < 15, continuous RRT, or unstable renal function 1. Give a one-time dose per nomogram 2. Check a random vancomycin level 24 hours after the dose 3. If random level is <20 mcg/mL, repeat dose 4. If random level is >20 mcg/mL, do not redose, repeat random level in 12 hours Patients on intermittent hemodialysis 1. Give a one-time dose per nomogram 2. Check a random vancomycin level 2 hours after hemodialysis 3. If random level is <20 mcg/mL, repeat dose 4. If random level is >20 mcg/mL, do not redose, repeat level after next dialysis |